Objective:

Assess whether a compact optical spectrometer can measure glucose, lactate, and alcohol through the skin.

Approach:

• Technology: The convolutional spectrometer (ConvSpec) uses near-infrared light and mathematical reconstruction to obtain detailed spectral information. The packaged device measures about 4.8 × 6.2 cm, weighs 16.5 g, and has an estimated component cost of $10; acquisition …
• Evaluation: Researchers used a wrist-worn optical probe to collect approximately 6,000 spectra across 126 participant sessions and compared measurements with conventional reference methods, including blood tests for glucose and lactate.

Key Findings:

• Mean absolute errors were 0.36 mmol/L for glucose, 0.81 mmol/L for lactate, and 1.70 mg/dL for alcohol.
• A personalized model tracked one participant’s glucose fluctuations over several days with a mean absolute error of 0.16 mmol/L.
• Glucose prediction models did not transfer reliably between individuals; skin characteristics and other physiological differences affected optical measurements.

Interpretation:

The study demonstrates experimental, noninvasive measurement of several biomarkers with a compact device. The reported results do not establish it as a validated alternative to laboratory testing.

Limitations:

• Glucose models did not generalize reliably across individuals.
• The context identifies a need for larger, more diverse datasets to improve generalizability.
• The technology remains experimental rather than a validated alternative to laboratory testing.

Conclusion:

The researchers describe ConvSpec as a compact, rapid approach that could support frequent biomarker monitoring outside laboratories, while noting that challenges remain before clinical implementation.

Sources:

• Article context; study described as published in Nature Photonics